期刊文献+

吉美嘧啶及其关键中间体的制备 被引量:1

The synthesis of gimeracil and its key intermediate
下载PDF
导出
摘要 目的经过工艺改进摸索精制吉美嘧啶及其关键中间体5-氯-3-氰基-4-甲氧基-2(1 H)吡啶酮的方法。方法以丙二腈、原乙酸三甲酯及1,1-二甲氧基三甲胺为起始原料,经过缩合、闭环、氯代及水解等一系列反应,制备替吉奥有效成分吉美嘧啶。结果精制后的中间体纯度在99.8%以上,单杂控制在0.1%以下。结论用精制后的中间体制备出吉美嘧啶,纯度在99.9%以上,总收率45%。此工艺成本低,容易操作,且适合工业化生产。 Objective To grope a new method for the purification of gimeracil and its key intermediate 5 - chloro - 4 - hy- droxy - 2 -( 1H ) - pyridone by improvement of technology. Methods The gimeracil was prepared from the raw materials mal- ononitrile, trimethyl orthoacetate and N, N - imethylfirmanmide dimethyl acetal by the reactions of condensation, cyclization, chlorination and hydrolysis. Results The purity of the intermediate was higher than 99.8% and the single impurity was lower than 0.1%. Conclusion The purity of the gimeracil was above 99.9% and the total yield was 45%. The process was low cost, easy operate and suitable for industrialized production
出处 《齐鲁药事》 2012年第3期132-133,共2页 qilu pharmaceutical affairs
关键词 吉美嘧啶 5-氯-4-羟基-2(1H)吡啶酮 中间体 Gimeracil 5 - chloro - 4 - hydroxy - 2 - ( 1H ) - pyridinone Intermediate
  • 相关文献

参考文献7

  • 1Ichikawa W,Takahashi T,Suto K. Thymidylate synthase predictive power is overcome by irinotecan combination theracy with S-1 for gastric cancer[J].British Journal of Cancer,2004,(07):1245-1250. 被引量:1
  • 2Kolder C R,Den Hertog H J. Synthesis and reactivity of 5-chloro-2,4-dihydroxypridine[J].Rec Trav Chim,1953,(02):285-295. 被引量:1
  • 3Den Hertog H J,Kolder C R. Migration of halogen atoms in halogeno-derivatives of 2,4-dihydroxypridine[J].Rec Trav Chim,1953,(08):853-858. 被引量:1
  • 4DEN H H J,COMBE W P,KOLDER C R. The reactivity of halogen atoms occupying positions 3 and 5 in 2,4-dihydroxy -pyridine[J].Rec Tray Chim,1953,(04):704-708. 被引量:1
  • 5Shio-go Yano,Tomoyasu Ohno,Kazuo Ogawa. Convenient and practical synthesis of 5-chloro-4hydroxy-2(1 H)pyridinone[J].Heterocycles,1993,(01):144-148. 被引量:1
  • 6郝玲花,周洁,孙延龙,王友奇,曾昭钧.吉莫斯特的合成[J].沈阳药科大学学报,2005,22(6):420-421. 被引量:4
  • 7徐云根;毛丹;张飞皇.5-氯-4-羟基-2(1H).-OH啶酮的制备方法及中间体-OH啶酮的制备方法及中间体[P].中国,(N)191597642006. 被引量:1

二级参考文献7

  • 1Ichikawa W, Takahashi T, Suto K, et al. Thymidylate synthase predictive power is overcome by irinotecan combination theracy with S-1 for gastric cancer[J]. British Journal of Cancer, 2004, 91(7):1245 - 1250. 被引量:1
  • 2Chollet P, Schoffski P, Weigang-kohler K, et al. Phase Ⅱ trial with S-1 in chemotherapy-na patients with gastric cancer. A trial performed by the EORTC early clinal studies group(ECSG)[J]. European Journal of Cancer,2003, (39): 1264-1270. 被引量:1
  • 3Mittelbach M, Kastner G, Junek H. Zur synthese von 4-hydroxynicotinsaure aus butadiendicarbonitrilen[J].Arch Pharm, 1985, 31:481-486. 被引量:1
  • 4Shio-go Yano, Tomoyasu Ohno, Kazuo Ogawa. Convenient and practical synthesis of 5-chloro-4-2 (1H)-pyridinone[J]. Heterocycles, 1993, 36(1): 144-148. 被引量:1
  • 5Kolder C R, den Hertog H J. Synthesis and reactivity of 5-chloro-2, 4-dihydroxypyridine[J]. Rec Tray Chim,1953, 72:285-295. 被引量:1
  • 6den Hertog H J, Kolder C R. Migration of halogen atoms in halogeno-derivatives of 2, 4-dihydroxypyridine[J].Rec Tray Chim, 1953, 72: 853-858. 被引量:1
  • 7den Hertog H J, Combe W P, Kolder C R. The reactivity of halogen atoms occupying positions 3 and 5 in 2, 4-dihydroxypyridine[J]. Rec Tray Chim, 1953, 73: 704-708. 被引量:1

共引文献3

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部